How is digital health shaping new forms of early-stage collaborations in biopharma?

Edition

How is digital health shaping new forms of early-stage collaborations in biopharma?

The new pathways created by digital advances in the Life Sciences sector offer R&D actors the opportunity to improve processes, efficiency, and results, all to strengthen the development of their innovations. These advances are now influencing the structure of entire organisations, creating new roles, requiring new skills, and calling for collaboration with new players. How is the digitalisation of the sector driving the appetite of industrials and entailing new collaborations? How is the change of interlocutors in organisations characterised in the context of collaborations between academic researchers, clinicians, and industry?

 

ModeratorDidier Tranchier, Co-Founder and Program Director, Digital Pharma Lab

Vassilis Georgiadis

Principal Partnerships Manager (Pharma & Healthcare)
United Kingdom
UCL Innovation and Enterprise

Carri Duncan

Managing Partner
Germany
Karaktero Capital

Fausto Artico

Global R&D Tech Head and Director of Innovation and Data Science
United Kingdom
GlaxoSmithKline

Manuel Gea

Co-founder, CEO, & EVP R&D IT and Systems
France
Bio-Modeling Systems
  • No products in the cart.